Header Logo

Connection

MACUS T KUO to Antineoplastic Agents

Back to Details
This is a "connection" page, showing publications MACUS T KUO has written about Antineoplastic Agents.
MACUS T KUO
Connection Strength
0.951
Antineoplastic Agents
  1. Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agents. Oncogene. 2016 Mar 31; 35(13):1632-42.
    View in: PubMed
    Score: 0.106
  2. Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals. J Biol Inorg Chem. 2014 Jan; 19(1):17-27.
    View in: PubMed
    Score: 0.094
  3. Overcoming platinum drug resistance with copper-lowering agents. Anticancer Res. 2013 Oct; 33(10):4157-61.
    View in: PubMed
    Score: 0.094
  4. Role of the human high-affinity copper transporter in copper homeostasis regulation and cisplatin sensitivity in cancer chemotherapy. Cancer Res. 2012 Sep 15; 72(18):4616-21.
    View in: PubMed
    Score: 0.087
  5. Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes. Oncotarget. 2010 Aug; 1(4):246-51.
    View in: PubMed
    Score: 0.075
  6. Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal. 2009 Jan; 11(1):99-133.
    View in: PubMed
    Score: 0.067
  7. The roles of copper transporters in cisplatin resistance. Cancer Metastasis Rev. 2007 Mar; 26(1):71-83.
    View in: PubMed
    Score: 0.059
  8. Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells. Mol Cancer Ther. 2004 Dec; 3(12):1543-9.
    View in: PubMed
    Score: 0.051
  9. Modulating Chemosensitivity of Tumors to Platinum-Based Antitumor Drugs by Transcriptional Regulation of Copper Homeostasis. Int J Mol Sci. 2018 May 16; 19(5).
    View in: PubMed
    Score: 0.032
  10. Transient induction of the MRP/GS-X pump and gamma-glutamylcysteine synthetase by 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3- nitrosourea in human glioma cells. Cancer Res. 1997 Dec 01; 57(23):5292-9.
    View in: PubMed
    Score: 0.031
  11. Posttranscriptional regulation of MRP/GS-X pump and gamma-glutamylcysteine synthetase expression by 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea and by cycloheximide in human glioma cells. Biochem Biophys Res Commun. 1997 Oct 09; 239(1):51-6.
    View in: PubMed
    Score: 0.031
  12. Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer. Oncotarget. 2017 Jul 25; 8(30):49275-49292.
    View in: PubMed
    Score: 0.031
  13. Autophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy. Int J Mol Sci. 2017 Jun 19; 18(6).
    View in: PubMed
    Score: 0.030
  14. Arginine deprivation in cancer therapy. Curr Opin Clin Nutr Metab Care. 2015 Jan; 18(1):78-82.
    View in: PubMed
    Score: 0.026
  15. Exploratory study of carboplatin plus the copper-lowering agent trientine in patients with advanced malignancies. Invest New Drugs. 2014 Jun; 32(3):465-72.
    View in: PubMed
    Score: 0.024
  16. Mechanistic basis for overcoming platinum resistance using copper chelating agents. Mol Cancer Ther. 2012 Nov; 11(11):2483-94.
    View in: PubMed
    Score: 0.022
  17. Overcoming platinum resistance through the use of a copper-lowering agent. Mol Cancer Ther. 2012 Jun; 11(6):1221-5.
    View in: PubMed
    Score: 0.021
  18. Inhibition of mTOR restores cisplatin sensitivity through down-regulation of growth and anti-apoptotic proteins. Eur J Pharmacol. 2008 Sep 04; 591(1-3):124-7.
    View in: PubMed
    Score: 0.016
  19. Arginine deprivation as a targeted therapy for cancer. Curr Pharm Des. 2008; 14(11):1049-57.
    View in: PubMed
    Score: 0.016
  20. The human multidrug resistance-associated protein (MRP) gene family: from biological function to drug molecular design. Clin Chem Lab Med. 2000 Sep; 38(9):893-7.
    View in: PubMed
    Score: 0.009
  21. Coordinated induction of MRP/GS-X pump and gamma-glutamylcysteine synthetase by heavy metals in human leukemia cells. J Biol Chem. 1996 Jun 21; 271(25):14981-8.
    View in: PubMed
    Score: 0.007
  22. Induction of MRP/GS-X pump and cellular resistance to anticancer prostaglandins. Cytotechnology. 1996; 19(3):221-7.
    View in: PubMed
    Score: 0.007
  23. How does the MRP/GS-X pump export doxorubicin? J Natl Cancer Inst. 1995 Nov 01; 87(21):1639-40.
    View in: PubMed
    Score: 0.007
  24. The relationship of thioredoxin-1 and cisplatin resistance: its impact on ROS and oxidative metabolism in lung cancer cells. Mol Cancer Ther. 2012 Mar; 11(3):604-15.
    View in: PubMed
    Score: 0.005
  25. Re: How does the MRP/GS-X pump export doxorubicin? J Natl Cancer Inst. 1996 Apr 03; 88(7):466-8.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.